Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study)
Status:
Terminated
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
Often it is necessary to temporarily discontinue OAT when surgical or other invasive
procedures are required. However, there is no consensus on the optimal management in these
situations, and heparin bridging therapy is the current usual practice in these situations.
No large randomized, controlled clinical trials have been yet performed to evaluate the
efficacy and safety of a low molecular weight heparins (LMWH) as bridging therapy.
Phase:
Phase 3
Details
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau